trial · primary record
Tirzepatide
Methamphetamine Use Disorder
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 228 |
| Primary completion | 2031-08 |
| Primary endpoint | Treatment response |
| Registry ID | NCT07825857 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:43.822Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07825857
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.